Cervical and Endometrial Cancer Screening in Patients Seeking Gender-Affirming Hysterectomy
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorUniversity of Minnesota
About this trial
This study aims to quantify the rates of cervical cancer screening and endometrial sampling prior to gender-affirming hysterectomy, assess the need for these tests in TGD individuals, and explore patient-centered options for these tests. By assessing the status of testing and correlation with hysterectomy pathology, this study will provide preliminary data on the current state of guideline-concordant care and provide initial evidence for the development of evidence-based guidelines in the future
Eligibility criteria
Qualifiers
18 years and older
Able to provide voluntary written consent prior to the performance of any research related activity. Patients who can provide informed consent
Able to understand, speak, read, and write in English
Patients who have undergone hysterectomy, or plan to have a hysterectomy
Disqualifiers
Opted out of research
<18 years old
Lacks capacity to consent/has diminished capacity to consent
Cannot provide informed consent
Trial design
Treatments tested in this trial
- No intervention
Treatment groups
40 Participants
are divided into 3 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov